Author

Belinda Yau

Primary ORCID profile (0000-0003-2303-7343 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Belinda YauiD3 papers · The University of Sydney

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew L. Coppage· 1 shared Angelina J. Lay· 1 shared Denise Ming Tse Yu· 1 shared Geoffrey W. McCaughan· 1 shared Gregory J. Cooney· 1 shared Hui Emma ZhangiD· 1 shared Jenny E. Gunton· 1 shared Kathryn A. Evans· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Andrew L. Coppage

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Fibroblast activation protein enzyme deficiency prevents liver steatosis, insulin resistance and glucose intolerance and increases fibroblast growth factor-21 in diet induced obese mice

Sumaiya Chowdhury, Sunmi Song, Hui Emma Zhang, Xin Maggie Wang, Margaret G. Gall, Denise Ming Tse Yu, Angelina J. Lay, Michelle Sui Wen Xiang, Kathryn A. Evans, Stefanie Wetzel, Yolanda Liu, Belinda Yau, Andrew L. Coppage, Lisa Lo, Rebecca A. Stokes, , Mark D. Gorrell

This study shows that FAP deficiency in diet-induced obese mice reduces liver steatosis, insulin resistance, and glucose intolerance while increasing FGF-21 levels.

bioRxiv · Nov 4, 2018 · PreprintPathology